Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.
Pinnacle Medicines has raised $89.0M in total funding. The most recent round was Series B. The last funding was announced in March 2026.
Pinnacle Medicines's investors include RA Capital Management, Qiming Venture Partners, OrbiMed, Foresite Capital, Quan Capital.
Pinnacle Medicines is headquartered in Doylestown, United States.
Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.
Pinnacle Medicines is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pinnacle Medicines — Funding & Investors." VCBacked, March 26, 2026, https://www.vcbacked.co/company/pinnacle-medicines. Accessed September 29, 2026.
VCBacked. (2026). Pinnacle Medicines — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/pinnacle-medicines
{{cite web |title=Pinnacle Medicines — Funding & Investors |url=https://www.vcbacked.co/company/pinnacle-medicines |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated